Formulary Search
A to Z of Drugs : S
Show Icon and Status Keys
- Tablets
Specialist team to initiate, up titrate and stabilise onto the maximum tolerated dose (for a minimum of 4 weeks), prior to transfer of care to primary care.
- Granules
Only licensed for use in children.
- Granules
This drug (for this indication) has not yet been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an application to the APC.
- Not Specified
- Inhaler (dry powder)
Cost-effective, low carbon DPI.
Prescribe by BRAND.
- Inhaler (dry powder)
Cost-effective, low carbon DPI.
Prescribe by BRAND.
- Nebules
Specialist* recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.
* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma
- Nebules
Specialist recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.
- Injection
- Modified release tablets
- Oral solution
- Tablets
- Inhaler (breath actuated Metered Dose)
Second line, as an alternative to Salbutamol Easyhaler, in patients needing a breath actuated inhaler
- Inhaler (breath actuated Metered Dose)
Second line, as an alternative to Salbutamol Easyhaler, in patients needing a breath actuated inhaler
- Inhaler (Metered Dose)
No dose counter. Lower carbon footprint than Ventolin Evohaler.
Prescribe by BRAND.
- Inhaler (Metered Dose)
No dose counter. Lower carbon footprint than Ventolin Evohaler.
Prescribe by BRAND.
- Inhaler (dry powder)
Easyhaler Salbutamol is preferred. Ventolin Accuhaler is a suitable low-carbon alternative DPI.
Not for initiation in new patients.
- Inhaler (dry powder)
Easyhaler Salbutamol is preferred. Ventolin Accuhaler is a suitable low-carbon alternative DPI.
Not for initiation in new patients.
- Inhaler (dry powder)
Easyhaler Salbutamol is preferred. Ventolin Accuhaler is a suitable low-carbon alternative DPI.
Prescribe by BRAND
- Inhaler (dry powder)
Easyhaler Salbutamol is preferred. Ventolin Accuhaler is a suitable low-carbon alternative DPI.
Prescribe by BRAND
- Inhaler (Metered Dose)
No dose counter. Higher carbon footprint than the Salamol MDI.
Not for initiation in new patients.
- Inhaler (Metered Dose)
No dose counter. Higher carbon footprint than the Salamol MDI.
Not for initiation in new patients.
- Infusion
- Ointment
- Topical solution
Treatment for warts & calluses should not be routinely prescribed in primary care. Available OTC
- Gel
- Paint
Treatment for warts & calluses should not be routinely prescribed in primary care. Available OTC
- Inhaler (dry powder)
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
- Inhaler (dry powder)
Serevent Evohaler
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
- Inhaler (Metered Dose)
Serevent Evohaler
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
- Inhaler (Metered Dose)
Serevent Evohaler
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
- Not Specified
- Not Specified
- Subcutaneous injection (sc)
- Tablets
- Tablets
- Powder
Prescribe on advice from specialist e.g. dietitian
- Ointment
- Suppositories
- Not Specified
- Subcutaneous injection (sc)
- Not Specified
- Subcutaneous injection (sc)
- Tablets
- Not Specified
- Capsules
- Oral solution
- Tablets
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
- Subcutaneous injection (sc)
- Tablets
- Injection
This drug has not yet been assessed for formulary status for the prevention of cardiovascular events. Contact your pharmacy team for advice on making an application to APC.
- Pre-filled pen
- Subcutaneous injection (sc)
- Liquid
- Tablets
- Tablets
- Tablets
Off-label.
- Tablets
- Tablets
- Tablets
- Eye drops
- Not Specified
- Tablets
- Orodispersible films
- Oromucosal spray
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
- Not Specified
- Not Specified
- Tablets
- Intravenous injection (IV)
RSFT ICU consultants only.
- Tablets
SASH only - under shared care agreement with tertiary centre.
- Tablets
- Caustic Applicator
- Pencil
Off-label use.
- Pencil
Licensed for umbilical granulomas only.
- Pencil
- Cream
1% cream.
- Oral suspension
- Suspension
- Liquid
Prescribe on advice from specialist e.g. dietitian
- Liquid
- Tablets
- Not Specified
This drug has not yet been assessed for formulary status. Contact your pharmacy team for advice on making an application to APC.
- Tablets
- Gel
- Not Specified
For EXISTING patients: GPs may continue to prescribe for existing post-transplant patients only. NHS England are looking to repatriate these patients in the future. GPs must not accept any new requests to prescribe for new patients.
- Not Specified
For NEW patients: RED drug for post-transplant. Funded by NHS England. GPs should not accept any requests to prescribe post-transplant.
- Tablets
- Barrier film foam
- Barrier film foam
- Barrier film foam
- Spray
- Spray
- Spray
- Wipes
- Wipes
- Wipes
- Wipes
- Powder
- Powder
- Liquid
- Liquid
- Liquid
- Powder
- Powder
Prescribe on advice from specialist e.g. dietitian up to 6 months corrected age
- Powder
- Liquid
Prescribe on advice from specialist e.g. dietitian
- Liquid
- Powder
- Liquid
- Not Specified
NHSE specialised commissioned services only. Not commissioned from any acute Trust in Surrey Heartlands.
However, this drug may be used in the emergency treatment of urea cycle disorders in patients on acute admission.
- Capsules
- Oral solution
- Tablets
https://www.toxbase.org/
https://www.toxbase.org/
- Capsules
- Tablets
- Ear drops
- Intravenous infusion
- Intravenous infusion
- Intravenous infusion
- Injection
https://www.toxbase.org/ . Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice
- Eye drops
- Eye drops (preservative free)
- Eye ointment
- Irrigation solution
- Irrigation solution
- Irrigation solution
- Not Specified
- Inhalation
- Nebules
- Inhalation
- Nebules
- Inhalation
- Nebules
- Inhalation
- Nebules
- Nasal drops
- Modified release tablets
- Enema
- Oral solution
- Capsules
Hypercalcaemia of malignancy. Bone metastases. Prevention of skeletal events.
Initiation and stabilisation for a minimum of 3 months by specialist team before any request for primary care prescribing.
- Tablets
Hypercalcaemia of malignancy. Bone metastases. Prevention of skeletal events.
Initiation and stabilisation for a minimum of 3 months by specialist team before any request for primary care prescribing.
- Capsules
- Tablets
For ENT specialist prescribing only
- Eye drops
- Capsules
- Oral solution
Prescribing for children: Express the dose in terms of elemental iron and iron salt and select the most appropriate preparation; specify both the iron salt and formulation on the prescription.
- Infusion
- Eye drops
- Eye drops (preservative free)
- Intra-ocular injection
- Intravenous injection (IV)
https://www.toxbase.org/ . Not a 1st-line treatment option. Consider if alternatives are unavailable. Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice
- Intravenous infusion
- Not Specified
- Granules
- Oral solution
- Tablets
NHSE specialised commissioned services only. Not commissioned from any acute Trust in Surrey Heartlands.
However, this drug may be used in the emergency treatment of urea cycle disorders in patients on acute admission.
- Oral solution
- Sachets (powder)
- Sachets (powder)
- Oral solution
- Sachets (powder)
- Sachets (powder)
- Oral solution
- Sachets (powder)
- Sachets (powder)
- Sachets (powder)
- Sachets (powder)
- Injection
- Intravenous injection (IV)
- Crushable tablets
- Gastro-resistant tablets
- Modified release tablets
- Oral solution
- Tablets
- Capsules (slow release)
- Granules (slow release)
- Injection
- Crushable tablets
- Gastro-resistant tablets
- Modified release tablets
- Oral solution
- Tablets
Pregnancy Prevention Programme required. See MHRA advice
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Capsules (slow release)
- Granules (slow release)
Pregnancy Prevention Programme required. See MHRA advice
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Injection
Pregnancy Prevention Programme required. See MHRA advice
- Not Specified
This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.
Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Sachets (powder)
- Tablets
- Tablets
- Not Specified
- Tablets
- Tablets
- Oral suspension
- Oral solution
- Tablets
- Cartridges
Initiation by diabetes team only
- Vials
- Cartridges
Prescribe by brand and state form.
- Solution for injection
- Injection
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Injection
- Subcutaneous injection (sc)
- Tablets
Sotagliflozin is not yet available in the NHS. The NICE TA622 will not be implemented until the product is available. Place in therapy will also be determined at this time.
- Tablets
- Infusion
Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service.
Hospital inpatients - as per local hospital guidelines.
- Liquid
- Infusion
This drug has not yet been assessed for formulary status. Contact your pharmacy team for advice on making an application to APC.
- Tablets
FEMALES ONLY - option for non-scarring alopecia
- Oral solution
- Tablets
- Oral solution
- Tablets
- Tablets
- Tablets
- Not Specified
- Not Specified
- Sachets (granules)
- Capsules
- Flange extenders
- Flange extenders
- Flange extenders
- Flange extenders
- Flange extenders
- Paste
- Paste
- Paste
- Paste
- Powder
- Lozenges
- Intrapleural injection
- Intravenous infusion
- Injection
- Sachets (granules)
Rheumatology only. Reserved for severe osteoporosis in patients for whom other treatment options are not suitable.
- Capsules
https://www.toxbase.org/ . Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice
- Oral suspension
- Tablets
Unlicensed product.
- Sublingual tablets
- Tablets
- Oral suspension
- Tablets
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Gastro-resistant tablets
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Suppositories
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Gastro-resistant tablets
- Oral suspension
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Injection
- Oral solution
- Tablets
Initiation by a SABP specialist and stabilisation for at least 3 months before any request to transfer prescribing responsibility.
- Oral suspension
- Injection
- Nasal spray
- Injection
- Nasal spray
- Tablets
- Tablets
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
- Lotion SPF 50
- Lotion SPF 50
- Liquid
Prescribe on advice from specialist e.g. dietitian
- Liquid
Prescribe on advice from specialist e.g. dietitian
- Liquid
Prescribe on advice from specialist e.g. dietitian
- Liquid
Enteral feeds should NOT be prescribed in primary care in Guildford and Waverley or North West Surrey. In Surrey Downs and East Surrey prescribe on request from specialist dietitian
- Not Specified
- Eye drops